, From Photos to Pharma, Kodak is having a moment
Eastman Kodak that’s been failing to make a mark on the Wall Street is now having a moment. Kodak stock tripled after the company announced it is pivoting to become a pharmaceutical powerful.
, US Govt Signs $2 billion deal with Pfizer for Covid-19 vaccines
The U.S. government has signed an agreement worth $1.95 billion with Pfizer and BioNTEch to produce and deliver 100 million doses of their Covid-19 vaccines. It is the largest such deal between the government and companies racing to develop a coronavirus vaccine.
, MultiPlan and Churchill Merge for $11 Billion, Company will go public
Churchill Capital Corp III, a special purpose acquisition company (SPAC), and MultiPlan Inc, a healthcare company, have agreed to merge in a deal worth $11 billion. The combined company will be called MultiPlan and will go public.
, Allstate Acquires National General for $4 billion in an all-cash deal
Allstate, the US insurance company, has agreed to acquire National General Holding Corp for $4 billion in an all-cash deal. Allstate is a leader …
, Stanford researchers develop a new ultrafast insulin
Researchers at Stanford University are working on a fast-acting ultrafast insulin formulation that acts four-times faster than the present formulations available in the market. …
, New Quick, Easy Covid-19 Test Will Help In Population Screening
Experts fighting the Covid-19 pandemic emphasize testing as a way to combat the virus from spreading faster. There is a constant search for a …
, Under Armour’s UA Sportsmask aimed at athletes sells out in an hour of launch
Under Armour launched a new facemask specifically aimed for sportspeople, making it easier to breathe while exercising. The UA Sportsmask was sold out online within …
, Fitbit Developed ‘Fitbit Flow,’ A Low-Cost Ventilator To Help COVID-19 Patients
Fitbit recently announced a significant development of a high-quality, low-cost, easy-to-use emergency ventilator, named Fitbit Flow. In response to the COVID-19 pandemic, the company created …
, Moderna Racing towards Second Phase of COVID Vaccine Trials
The COVID-19 coronavirus pandemic has affected 6 million people worldwide since it started spreading nearly six months ago. There have been 376,000 reported deaths …
, AstraZeneca to Begin Supplying COVID-19 Vaccine in September
The University of Oxford and AstraZeneca Plc have begun recruiting over 10,000 subjects for advanced human trials of experimental COVID-19 vaccine. If everything goes …
, Remdesivir Shortens Recovery Period of Covid-19 Patients, Still Under Experiment
Remdesivir, an experimental drug, is being tested on patients to determine its efficacy against the COVID-19 in people suffering from mild to severe respiratory …
, ATMOBLUE: Smart Mask That Delivers 99.5% Filtered Air
Face masks have become the most ubiquitous item of functionality in today’s world. Earlier, only health care workers and hygiene conscious and pollution weary …
, Surge In Demand for Marijuana during Lockdown Favors Pot Stocks
Pot stocks are seeing unprecedented gains after suffering some initial lows in the coronavirus crisis. As the coronavirus spread, the United States government and …
, Gene-editing feature CRISPR could restore sight to blind people
CRISPR inspires new hope to the visually impaired.
, Shortfall in diagnostic kits for coronavirus shows preparation gap in US healthcare facilities
Coronavirus has been declared a pandemic by the World Health Organization. This global crisis has plunged the world into a state of panic with …
, Pharma Industry faces clinical trial woes due to Coronavirus in China
The Covid 19 Coronavirus far from being contained is finding new victims every day. With almost all parts of the world reporting cases, concerns …
, Thermo Fisher pays $11.5 billion for Qiagen NV
Thermo Fisher Scientific Inc., the laboratory equipment manufacturer, plans to acquire Qiagen NV, a Dutch diagnostics and molecular testing company for $11.5 billion. The deal …
, World Bank Pandemic Bonds face losses following Coronavirus spread
Investors holding the World Bank’s Pandemic bonds may be facing losses as the coronavirus outbreak spreads to more countries and the death rate escalates. The …
, PPD Raises $1.6 Billion in IPO
PPD Inc, the drug research and biotech company, raised more than $1.6 billion in its initial public offering. Its 60 million shares were sold …
, Researchers Reverse HIV Dormancy, Paving Way for Better Treatment of Disease
A full cure for Human immunodeficiency Virus (HIV) has been hindered by the inability of scientists to contain latency of the disease in hidden …
, What Novartis’ Potential Acquisition of The Medicines Company Means for the Industry Leader
In the recent deal, Novartis on 24th November 2019 announced that it was going to buy The Medicines Company for $9.7 billion. The pharmaceutical …
